Brief: MangoRX Initiates Efficacy Studies On Patented Technology For Respiratory Illness Prevention
24/07/2024 13:51
July 24 (Reuters) - Mangoceuticals Inc MGRX.O :
* MANGORX INITIATES EFFICACY STUDIES ON ITS PATENTED
RESPIRATORY
ILLNESS PREVENTION TECHNOLOGY
* MANGOCEUTICALS INC - STUDIES TO CONCLUDE EARLY Q3
Source text for Eikon: ID:nGNX7VbxdM
Further company coverage: MGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mangoceuticals
See all newsBrief: Mangoceuticals And Nuclea Energy Terminate Business Combination Agreement On August 19
Brief: Mangoceuticals Inc.’S Merger Partner, Nuclea Energy, Inc., Enters Into Definitive Agreement To Acquire Moltex Energy’S Advanced Nuclear Technology Assets
NASDAQ RESUMED AT 10:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:30 AM
NASDAQ RESUMED AT 10:27 AM